OHRP/FDA Should Issue Adverse Event Reporting Guidance, Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The HHS Secretary’s Advisory Committee on Human Research Protections is urging FDA and the Office for Human Research Protections to issue guidance facilitating the ability of institutional review boards to “interpret and apply” federal regulations to the review of internal and external AE reports.